Literature DB >> 17805942

The role of the hypoxia-inducible BH3-only proteins BNIP3 and BNIP3L in cancer.

Howard R Mellor1, Adrian L Harris.   

Abstract

In this review, we summarize current knowledge of the biological functions of the atypical BH3-only proteins BNIP3 and BNIP3L, focusing on the role of these proteins in cancer. Hypoxia increases the expression of BNIP3 through the transcription factor HIF-1, but despite a considerable number of investigations, it has proven difficult to establish a clear role for BNIP3 in the cellular hypoxic response. BNIP3 can induce a form of cell death that shows features of both necrosis and apoptosis, but unusually for a BH3-only protein, death occurs independently of the BH3 domain and is critically dependent on a C-terminal transmembrane domain, which also localizes the protein to the mitochondria. BNIP3 expression does not always result in cell death, suggesting that additional factors may suppress BNIP3 or cooperate with it to induce death. BNIP3 is highly expressed in some tumors, including those of the breast, lung and cervix. However, in colorectal and pancreatic cancers BNIP3 is frequently epigenetically silenced, possibly reflecting different functions for BNIP3 in different tissues. Recent reports have shown that BNIP3 can induce autophagy and there is some evidence to suggest this may represent an emerging role for BH3-only proteins in general. However, the mechanism through which BNIP3 induces autophagy and the cellular consequences of this are yet to be established.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17805942     DOI: 10.1007/s10555-007-9080-0

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN: 0167-7659            Impact factor:   9.264


  46 in total

1.  A comprehensive glossary of autophagy-related molecules and processes (2nd edition).

Authors:  Daniel J Klionsky; Eric H Baehrecke; John H Brumell; Charleen T Chu; Patrice Codogno; Ana Marie Cuervo; Jayanta Debnath; Vojo Deretic; Zvulun Elazar; Eeva-Liisa Eskelinen; Steven Finkbeiner; Juan Fueyo-Margareto; David Gewirtz; Marja Jäättelä; Guido Kroemer; Beth Levine; Thomas J Melia; Noboru Mizushima; David C Rubinsztein; Anne Simonsen; Andrew Thorburn; Michael Thumm; Sharon A Tooze
Journal:  Autophagy       Date:  2011-11-01       Impact factor: 16.016

2.  Common pitfalls in preclinical cancer target validation.

Authors:  William G Kaelin
Journal:  Nat Rev Cancer       Date:  2017-05-19       Impact factor: 60.716

3.  A comprehensive glossary of autophagy-related molecules and processes.

Authors:  Daniel J Klionsky; Patrice Codogno; Ana Maria Cuervo; Vojo Deretic; Zvulun Elazar; Juan Fueyo-Margareto; David A Gewirtz; Guido Kroemer; Beth Levine; Noboru Mizushima; David C Rubinsztein; Michael Thumm; Sharon A Tooze
Journal:  Autophagy       Date:  2010-05-16       Impact factor: 16.016

4.  Distinct microRNA expression signatures are associated with melanoma subtypes and are regulated by HIF1A.

Authors:  Hun-Way Hwang; Laura L Baxter; Stacie K Loftus; Julia C Cronin; Niraj S Trivedi; Bhavesh Borate; William J Pavan
Journal:  Pigment Cell Melanoma Res       Date:  2014-05-27       Impact factor: 4.693

5.  Expression and subcellular localization of BNIP3 in hypoxic hepatocytes and liver stress.

Authors:  Mallikarjuna R Metukuri; Donna Beer-Stolz; Rajaie A Namas; Rajeev Dhupar; Andres Torres; Patricia A Loughran; Bahiyyah S Jefferson; Allan Tsung; Timothy R Billiar; Yoram Vodovotz; Ruben Zamora
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-01-15       Impact factor: 4.052

Review 6.  Hypoxia inducible factor 1 as a therapeutic target in ischemic stroke.

Authors:  Honglian Shi
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

7.  BH3 mimetics reactivate autophagic cell death in anoxia-resistant malignant glioma cells.

Authors:  Holger Hetschko; Valerie Voss; Christian Senft; Volker Seifert; Jochen H M Prehn; Donat Kögel
Journal:  Neoplasia       Date:  2008-08       Impact factor: 5.715

8.  Homozygous deletions and recurrent amplifications implicate new genes involved in prostate cancer.

Authors:  Wennuan Liu; Chunmei Carol Xie; Yi Zhu; Tao Li; Jishan Sun; Yu Cheng; Charles M Ewing; Sue Dalrymple; Aubrey R Turner; Jielin Sun; John T Isaacs; Bao-Li Chang; Siqun Lilly Zheng; William B Isaacs; Jianfeng Xu
Journal:  Neoplasia       Date:  2008-08       Impact factor: 5.715

9.  LNCaP Atlas: gene expression associated with in vivo progression to castration-recurrent prostate cancer.

Authors:  Tammy L Romanuik; Gang Wang; Olena Morozova; Allen Delaney; Marco A Marra; Marianne D Sadar
Journal:  BMC Med Genomics       Date:  2010-09-24       Impact factor: 3.063

10.  Expression of BNIP3 in invasive breast cancer: correlations with the hypoxic response and clinicopathological features.

Authors:  Esther A Koop; Theo van Laar; Dick F van Wichen; Roel A de Weger; Elsken van der Wall; Paul J van Diest
Journal:  BMC Cancer       Date:  2009-06-09       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.